Mr. Craig Neal Willimann, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Dwayne Vonbehren Dr, New Haven, MO 63068 Phone: 573-237-2912 Fax: 573-237-2005 |
News Archive
The U.S FDA have pushed back the deadline for deciding whether to approve an experimental anticlotting drug developed jointly by Pfizer Inc. and Bristol-Myers Squibb Co. The companies said late Wednesday that the Food and Drug Administration has set a new target date of June 28 for deciding whether to approve Eliquis. That's three months later than originally scheduled.
Moffitt Cancer Center researchers suggest secondary cancers seen in melanoma patients who are being treated for a BRAF gene mutation may require new strategies, such as enhanced surveillance and combining BRAF-inhibitor therapy with other inhibitors, especially as they become more widely used.
On October 29, the inter-agency Drug Shortages Task Force led by the U.S. Food and Drug Administration issued a report titled "Drug Shortages: Root Causes and Potential Solutions" at the request of Congress.
The Children's Medical Center Research Institute at UT Southwestern has deepened the understanding of the environment within bone marrow that nurtures stem cells, this time identifying the biological setting for specialized blood-forming cells that produce the infection-fighting white blood cells known as T cells and B cells.
› Verified 8 days ago